AMERIPRISE FINANCIAL INC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AC4. A total of 24 filers reported holding CLOVIS ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$29,537,000
-0.0%
42,200,0000.0%0.01%
+10.0%
Q2 2022$29,540,000
-6.7%
42,200,0000.0%0.01%
+11.1%
Q1 2022$31,651,000
+7.9%
42,200,0000.0%0.01%
+12.5%
Q4 2021$29,333,000
-3.6%
42,200,0000.0%0.01%
-20.0%
Q3 2021$30,438,000
-1.6%
42,200,0000.0%0.01%0.0%
Q2 2021$30,948,000
-2.9%
42,200,0000.0%0.01%
-9.1%
Q1 2021$31,887,000
+9.5%
42,200,000
+0.5%
0.01%
+10.0%
Q4 2020$29,131,000
-0.9%
42,000,0000.0%0.01%
-16.7%
Q3 2020$29,395,000
+15.6%
42,000,0000.0%0.01%
+9.1%
Q2 2020$25,430,000
+10.3%
42,000,000
+7.7%
0.01%
-8.3%
Q1 2020$23,047,000
+5.7%
39,000,000
+12.2%
0.01%
+33.3%
Q4 2019$21,806,000
+60.6%
34,750,000
+6.9%
0.01%
+50.0%
Q3 2019$13,582,000
-34.8%
32,500,000
-3.0%
0.01%
-33.3%
Q2 2019$20,841,000
-12.4%
33,500,000
+9.8%
0.01%
-18.2%
Q1 2019$23,785,000
+26.8%
30,500,000
+13.8%
0.01%
+22.2%
Q4 2018$18,756,000
+17.8%
26,800,000
+30.1%
0.01%
+50.0%
Q3 2018$15,923,000
-9.0%
20,600,000
+8.4%
0.01%
-25.0%
Q2 2018$17,497,00019,000,0000.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2020
NameSharesValueWeighting ↓
Castle Creek Arbitrage, LLC 3,000,000$1,874,0000.49%
Opti Capital Management, LP 4,500$2,815,0000.42%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 30,000,000$18,578,000,0000.36%
CAMDEN ASSET MANAGEMENT L P /CA 17,336,000$10,785,0000.34%
CSS LLC/IL 5,850,000$3,650,0000.21%
MIZUHO SECURITIES USA LLC 4,000,000$2,504,0000.12%
FARALLON CAPITAL MANAGEMENT LLC 18,750,000$11,684,0000.08%
ADVENT CAPITAL MANAGEMENT /DE/ 4,516,000$2,834,0000.06%
AQR Arbitrage LLC 7,350,000$4,609,0000.05%
ARROWGRASS CAPITAL PARTNERS (US) LP 8,000$1,562,0000.04%
View complete list of CLOVIS ONCOLOGY INC shareholders